Literature DB >> 7634678

Metastatic retinoblastoma. Recent progress of interest to orthopaedic surgeons.

J E Blank1, J P Dormans, B P Himelstein, D Yamashiro.   

Abstract

Retinoblastoma is the most common malignant intraocular neoplasm of childhood. Distant metastases to bone and bone marrow occur. The authors report on a retinoblastoma patient with metastases to the extraaxial skeleton. Implications for the orthopaedic surgeon and alternative diagnostic modalities are discussed. The case presented here exemplifies the potential role for the orthopaedic surgeon in making such a diagnosis in a child previously treated for retinoblastoma. Secondary nonocular malignant tumors should be considered in the differential diagnosis of patients with a history of retinoblastoma who have a painful extremity. Radiation treatment of the primary tumor increases the risk for nonocular secondary neoplasms. The structural alterations in the retinoblastoma gene in patients with osteosarcomas and the possible role of the retinoblastoma gene in the origin of osteosarcomas are also discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7634678

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Isolated lower extremity metastases, 9 years after initial diagnosis of retinoblastoma.

Authors:  M E Mulligan; S E Smith; E F McCarthy
Journal:  Skeletal Radiol       Date:  2005-06-07       Impact factor: 2.199

2.  Successful Treatment of Late Isolated Bone Metastasis in a Patient with Bilateral Retinoblastoma Using an Unconventional Method.

Authors:  Deepthi Boddu; Priyakumari Thankamony; Reshma Prakasam; Subin Sugath; Aswin Kumar; Sindhu Nair
Journal:  Ocul Oncol Pathol       Date:  2021-04-14

3.  Bilateral retinoblastoma presenting as metastases to forearm bones four years after the initial treatment.

Authors:  Manohar Kuruva; Bhagwant Rai Mittal; Raghava Kashyap; Anish Bhattacharya; Ram Kumar Marwaha
Journal:  Indian J Nucl Med       Date:  2011-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.